SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-15-303582
Filing Date
2015-08-27
Accepted
2015-08-26 20:21:59
Documents
2
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. IV, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d40810dsc13da.htm SC 13D/A 90417
2 EX-99.A d40810dex99a.htm EX-99.A 9332
  Complete submission text file 0001193125-15-303582.txt   101409
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 024511215 7812900770
POLARIS VENTURE PARTNERS IV LP (Filed by) CIK: 0001157864 (see all company filings)

IRS No.: 043571023 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Subject) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87630 | Film No.: 151076993
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences